Maggiolo F - Search Results

1

Evolution of antiretroviral prescription and response over a period of 8 years: an Italian multicentre observational prospective cohort study.

Sighinolfi L, Torti C, Zeni C, Ghinelli F, Suter F, Maggiolo F, Antinori A, Antonucci G, Castelnuovo F, Ladisa N, Migliorino M, Novati S, De Luca A, Lo Caputo S, Paraninfo G, Tinelli C, Carosi G; Italian MASTER Database Cohort. Sighinolfi L, et al. Among authors: maggiolo f. Infection. 2008 Jun;36(3):244-9. doi: 10.1007/s15010-007-7227-0. Epub 2008 May 3. Infection. 2008. PMID: 18454340

2

Teicoplanin versus cefamandole in the prevention of infection in total hip replacement.

Suter F, Avai A, Fusco U, Gerundini M, Caprioli S, Maggiolo F. Suter F, et al. Among authors: maggiolo f. Eur J Clin Microbiol Infect Dis. 1994 Oct;13(10):793-6. doi: 10.1007/BF02111338. Eur J Clin Microbiol Infect Dis. 1994. PMID: 7889947 Clinical Trial.

3

Bactericidal activity of two different dosage regimens of imipenem in an in-vitro dynamic model.

Maggiolo F, Taras A, Frontespezi S, Bottari F, Legnani MC, Suter F. Maggiolo F, et al. J Antimicrob Chemother. 1993 Aug;32(2):295-300. doi: 10.1093/jac/32.2.295. J Antimicrob Chemother. 1993. PMID: 8226431

4

Zidovudine and thymus humoral factor gamma-2 in the treatment of HIV infection: preliminary clinical experience.

Maggiolo F, Taras A, Pravettoni MG, Leone M, Ingrosso A, Suter F. Maggiolo F, et al. Infection. 1997 Jan-Feb;25(1):35-8. doi: 10.1007/BF02113505. Infection. 1997. PMID: 9039536 Clinical Trial.

5

Elevated concentrations of plasma alpha-melanocyte stimulating hormone are associated with reduced disease progression in HIV-infected patients.

Airaghi L, Capra R, Pravettoni G, Maggiolo F, Suter F, Lipton JM, Catania A. Airaghi L, et al. Among authors: maggiolo f. J Lab Clin Med. 1999 Mar;133(3):309-15. doi: 10.1016/s0022-2143(99)90087-2. J Lab Clin Med. 1999. PMID: 10072263

6

Salvage therapy in HIV-positive patients with a previous therapeutic experience with protease inhibitors. Members of the Master Group.

Maggiolo F, Maserati R, Pan A, Castelli F, Suter F. Maggiolo F, et al. AIDS. 1999 Aug 20;13(12):1591-2. doi: 10.1097/00002030-199908200-00027. AIDS. 1999. PMID: 10465091 No abstract available.

7

Changes in plasma HIV-RNA and CD4 lymphocyte counts in patients receiving highly active antiretroviral therapy.

Maggiolo F, Bottura P, Capra R, Pirali A, Zaffaroni P, Suter F. Maggiolo F, et al. AIDS. 1999 Aug 20;13(12):1594-5. doi: 10.1097/00002030-199908200-00029. AIDS. 1999. PMID: 10465093 No abstract available.

8

Different immunologic profiles characterize HIV infection in highly active antiretroviral therapy-treated and antiretroviral-naïve patients with undetectable viraemia. The Master Group.

Clerici M, Seminari E, Suter F, Castelli F, Pan A, Biasin M, Colombo F, Trabattoni D, Maggiolo F, Carosi G, Maserati R. Clerici M, et al. Among authors: maggiolo f. AIDS. 2000 Jan 28;14(2):109-16. doi: 10.1097/00002030-200001280-00005. AIDS. 2000. PMID: 10708280

9

Effects of subinhibitory concentrations of moxifloxacin in an in-vitro dynamic model.

Maggiolo F, Capra R, Bartoli A, Bottura P, Migliorino M, Suter F. Maggiolo F, et al. J Chemother. 2000 Apr;12(2):129-33. doi: 10.1179/joc.2000.12.2.129. J Chemother. 2000. PMID: 10789551

10

Quantification of the impact of HIV-1 reverse transcriptase and protease mutations on the efficacy of rescue HAART.

Paolucci S, Baldanti F, Maserati R, Castelli F, Suter F, Maggiolo F, Pan A, Gerna G. Paolucci S, et al. Among authors: maggiolo f. Antiviral Res. 2000 Feb;45(2):101-14. doi: 10.1016/s0166-3542(00)00062-0. Antiviral Res. 2000. PMID: 10809019

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

341 results

Search Page

Filters